People: Alteryx Inc (AYX.N)

AYX.N on New York Stock Exchange

18 Sep 2020
Change (% chg)

$0.74 (+0.69%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Maudlin, Timothy 

Mr. Timothy I. Maudlin serves as Independent Director of the Company. Mr. Maudlin served as the Managing General Partner of Medical Innovation Partners, a venture capital firm, from 1989 to 2007. Mr. Maudlin also served as a Principal and the Chief Financial Officer of Venturi Group, LLC, an incubator and venture capital firm, from 1999 to October 2001. Mr. Maudlin has served as a member of the board of directors of Pluralsight, Inc. since its formation in December 2017 and as a member of the board of managers of Pluralsight Holdings, LLC since June 2016. Mr. Maudlin previously served as a member of the board of directors of ExactTarget, Inc. from May 2008 to July 2013, MediaMind Technologies, Inc. from August 2008 to June 2011, Sucampo Pharmaceuticals, Inc. from September 2006 to February 2013 and Web.com Group, Inc. from February 2002 to October 2018. Mr. Maudlin is also currently a member of the board of directors of several private companies. Mr. Maudlin is a certified public accountant (inactive) and holds a B.A. in economics from St. Olaf College and a M.M. in accounting, finance and management from the Kellogg School of Management at Northwestern University. We believe that Mr. Maudlin is qualified to serve on our board of directors because of his extensive financial and accounting experience gained from his experience in the venture capital industry and extensive experience serving on boards of directors of various private and public technology companies.

Basic Compensation

Total Annual Compensation, USD 50,000
Restricted Stock Award, USD 177,151
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 227,151

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Dean Stoecker


Robert Jones


Olivia Adams


Kevin Rubin


Scott Davidson


Christopher Lal

As Of  31 Dec 2019